Pharmacists can do more to bridge the safety gaps for people with learning disabilities People with learning disabilities are more likely to be taking multiple medicines, but labels are not designed with them in mind — it is time to pay more attention to this patient group’s needs.…
Colchicine for cardiovascular disease: is UK clinical practice missing out? A deep dive into whether colchicine, an ancient treatment for inflammation, has a future in cardiovascular disease therapy in the UK.…
‘Game changing’ cancer drug to be withdrawn by manufacturer Takeda — manufacturer of Exkivity (mobocertinib), which is used to treat a rare form of lung cancer — has announced it intends to withdraw the drug after it did not meet its primary endpoint in a phase III trial.…
PSA writes to health secretary to ‘raise concerns’ over GPhC’s fitness-to-practise timeliness Duncan Rudkin, chief executive of the GPhC, said it was “an absolute priority” for it to resolve fitness-to-practise cases “in a timely way”.…
Hydrocortisone manufacturers to be fined almost £130m after tribunal upholds ruling The Competition and Markets Authority said NHS spending on hydrocortisone tablets rose from £0.5m per year to over £80m.…
GPhC facing biggest ever backlog of open fitness-to-practise cases at initial assessment stage Council papers said there were more than 700 open initial assessment fitness-to-practise cases.…
Shortage of scabies treatment ‘likely to become a major public health issue’ The government has issued a medicine supply notification warning that permethrin 5% w/w cream will be “in limited supply until further notice due to an increase in demand”.…
Bupropion to be made available in the UK again from December 2023, says manufacturer Exclusive: GSK has told The Pharmaceutical Journal that bupropion tablets will be available “across the EU and Europe on or before the end of December 2023”.…
RPS says codeine linctus should be made a prescription-only medicine, in response to MHRA consultation The Royal Pharmaceutical Society says reclassification will make it easier to monitor codeine linctus use, because it will be recorded in GP systems.…
Uncompassionate use: the inconsistent offering of life-saving unlicensed medicines Compassionate use schemes offered by pharmaceutical companies are struggling to live up to their name, as data from a third of acute trusts reveal an inequitable provision of medicines through schemes across England.…